News for Beyond Air, Inc. (XAIR)

Distribution agreements recently signed for France, Turkey, Romania and Morocco LungFit PH international distribution network now includes 18 countries Initia

Significant Transaction by Alyeska Investment Group On December 31, 2024, Alyeska Investment Group, L.P. (Trades, Portfolio) executed a noteworthy transaction b

Introduction to the Transaction On December 31, 2024, Balyasny Asset Management L.P. (Trades, Portfolio) executed a noteworthy transaction by acquiring 12,290,9

Beyond Air, Inc. (NASDAQ:XAIR) Q3 2025 Results Conference Call February 10, 2025 4:30 PM ETCompany ParticipantsCorey Davis - Investor Relations, LifeSci...

Beyond Air (XAIR) delivered earnings and revenue surprises of 16.67% and 9.39%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

**media[537050]**

Beyond Air Inc (XAIR) is set to release its Q3 2025 earnings on Feb 10, 2025. The consensus estimate for Q3 2025 revenue is $0.93 million, and the earnings are

Beyond Air (XAIR) has been granted a 180-day compliance period by Nasdaq, with no immediate effect on the trading of its common stock.

Discover potential implications of Beyond Air (XAIR) filing for an important financial document in the latest update.

**media[525582]**

GARDEN CITY, N.Y., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. ( XAIR) (”œBeyond Air” or the ”œCompany”), a commercial stage medical device and b

Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Beyond Air (XAIR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Indication covers newborn infants with hypoxic respiratory failure and peri- and post-operative pulmonary hypertension to improve right ventricular function in

Professor Kornberg will assist in accelerating the development of treatments for Autism Spectrum Disorder and potentially other neurological disorders DUBLIN

**media[476562]**

Nov 11, 2024 / 09:30PM GMTOperator Good afternoon, and welcome, everyone, to the Beyond Air financial results call for the fiscal quarter ended September 30, 20

Beyond Air, Inc. (NASDAQ:XAIR) Q2 2025 Earnings Conference Call November 11, 2024 4:30 PM ETCompany ParticipantsCorey Davis - Investor Relations, LifeSci...

Cutera Inc. (CUTR) experienced a significant stock price decline of 5.14%, bringing its price to $0.751 per share. The trading volume reached 26,733 shares, wit